A randomized, placebo-controlled, multicenter phase-II-study to investigate the protectivity and efficacy of metformin in combination with FOLFIRI and cetuximab in patients with previously untreated, KRAS-wild-type, metastatic colorectal cancer
|Coordinating investigator:||Grünberger, Birgit; Vienna|
(Click to enlarge)
Link for studyteam-members only
Further information about this trial
Access to these informations only with keyword. If required, please ask the responsible project manager.